Products Medical Products CEO Phillip Frost (Mar 2007–) Founded 1991 | Traded as NYSE: OPKTASE: OPK Website www.opko.com Founder Phillip Frost | |
 | ||
Industry Medical Appliances & Equipment Stock price OPK (NASDAQ) US$ 7.93 -0.07 (-0.88%)21 Mar, 3:26 PM GMT-4 - Disclaimer Headquarters Miami, Florida, United States Subsidiaries Bio-Reference Laboratories, Inc. | ||
Opko health inc opk stock chart technical analysis for 12 30 16
OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company develops treatments for secondary hyperparathyroidism, and has recently finished the patient recruitment for a Phase III trial against insufficiency in Vitamin D. The company is a publicly traded company on NYSE under the symbol "OPK". It acquired Laboratorio Arama de Uruguay in 2014 and is seeking to expand its presence in Uruguay and Argentina.
Contents
Learn more about opko health
History
OPKO Health Incorporation focuses on production of cardiovascular products, vaccines, hormones, antibiotics, gastrointestinal products, and eye care. The company operates in the U.S., Chile, Israel, Mexico, Uruguay, and Spain.
Production
The productions of OPKO Health Incorporation include mainly two segments: Pharmaceuticals and Diagnostics. The company is recently expanding collaboration with Bristol-Myers Squibb Co. on diagnostic test technology, which involves blood tests identifying biomarkers of diseases.
Corporate affairs
In December 2013 OPKO Health completed the sale of its stake in Sorrento Therapeutics. The company entered into a stock purchase agreement with Sorrento in 2009.
Stocks
The ticker symbol for OPKO Health Incorporation is "OPK", under which the company went public on NYSE.